FOXO closes acquisition of Vector Bio Source; $500K cash, preferred stock, and warrants

FOXO TECHNOLOGIES INC.

On Sept 19, 2025, FOXO completed the purchase of Vector Bio Source, which became a wholly owned subsidiary.
Total consideration: $500,000 cash, 60,000 Series E Cumulative Redeemable Secured Preferred Shares, and warrants for up to $2M of common stock.
Warrants have an exercise price of $0.00517 per share and a 9.99% beneficial ownership limitation.
Shares and warrants were issued in a private placement exempt from registration under Section 4(a)(2) and Rule 506(b).

item 2.01item 3.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.